NO-1886

• 产品号: N1540
• CAS号: 133208-93-2
• 分子式: C19H20BrN2O4P
• 分子量: 451.250861
• 纯 度: ≥98% (HPLC)

产品别名

• 标题: NO-1886
• IUPAC标准名: diethyl ({4-[(4-bromo-2-cyanophenyl)carbamoyl]phenyl}methyl)phosphonate
• IUPAC传统名: ibrolipim
• 别名: Diethyl 4-[(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate; OPF 009; Ibrolipim

产品登记号

• MDL号: MFCD00897807
• CAS号: 133208-93-2

产品性质

• Empirical Formula (Hill Notation): C19H20BrN2O4P
• 纯度: ≥98% (HPLC)
• 外观: off-white to pale yellow powder
• 溶解度: DMSO: ≥20 mg/mL
• GHS警示词: Danger
• GHS危险声明: H301
• 欧盟危险性物质标志: 有毒(Toxic) (T)
• GHS警示性声明: P301 + P310
• 危险公开号: 25
• 安全公开号: 45
• 保存温度: 2-8°C
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Biochem/physiol Actions
Lipoprotein lipase activator. Overexpression of lipoprotein lipase in transgenic rabbits leads to increased small dense LDL in plasma and promotes atherosclerosis. Long-term administration of NO-1886 protects against the development of experimental atherosclerosis in animals.
Packaging
Packaged under nitrogen

详细说明 (简体中文)

Biochem/physiol Actions
Lipoprotein lipase activator. Overexpression of lipoprotein lipase in transgenic rabbits leads to increased small dense LDL in plasma and promotes atherosclerosis. Long-term administration of NO-1886 protects against the development of experimental atherosclerosis in animals.
包装
Packaged under nitrogen